Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199676 · ClinicalTrials.gov registry record
Immediate Postpartum Glucose Tolerance Testing
A clinical trial of Gestational Diabetes, sponsored by MemorialCare Health System.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT04199676 is a study of Gestational Diabetes that is actively recruiting participants, run by MemorialCare Health System. The registered enrollment target is 300 participants, roughly in line with the 315-participant average among 41 other Gestational Diabetes trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04199676, a study of Gestational Diabetes, is actively recruiting participants, sponsored by MemorialCare Health System.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Glucose tolerance test
Study Locations (1)
California
- Long Beach Memorial Medical Center/Miller Children's and Women's Hospital - Long Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04199676
The ClinicalTrials.gov registry entry for NCT04199676 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 315-participant average among 41 other Gestational Diabetes trials with a reported enrollment target. The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Glucose tolerance test is the first listed.
NCT04199676 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04199676 about?
NCT04199676 is a clinical study titled "Immediate Postpartum Glucose Tolerance Testing". The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered i...
What is the current status of trial NCT04199676?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-09-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04199676 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT04199676?
The interventions under investigation include: Glucose tolerance test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04199676?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04199676 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Growth Hormone Resistance of Beta-cells
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.